Synlogic, Inc. (0A8U.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
As of 08:15AM BST. Market open.
| Previous close | 0.9300 |
| Open | 0.0000 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 0.0000 - 0.0000 |
| 52-week range | |
| Volume | |
| Avg. volume | N/A |
| Market cap | N/A |
| Beta (5Y monthly) | 1.02 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Synlogic, Inc. (SYBX) Reports Q4 Loss, Misses Revenue Estimates
Synlogic, Inc. (SYBX) delivered earnings and revenue surprises of 7.69% and 73.50%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
Will Synlogic (NASDAQ:SYBX) Spend Its Cash Wisely?
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
- Yahoo Finance Video
Ginkgo Bioworks partners with Synlogic on new gout drug
Ginkgo is teaming up with Synlogic to launch a new gout drug, moving shares of both stocks higher.
© 2023 Yahoo. All rights reserved.
